GlassScriptPhysician profile
Andrew K Romeo
NPI 1699064329
$12,452.26
in general payments reported to CMS, 2019-2025
18 companies · $589 in 2025
The $589 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,382 · 2020: $457 · 2021: $821 · 2022: $957 · 2023: $2,693 · 2024: $555 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943 · Travel and Lodging: $1,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.42 |
| Travel and Lodging | $1,892.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $6,464.25 | 2019-2020 | |
| Inspire Medical Systems, INC. | $1,577.10 | 2023-2025 | Inspire |
| Abbott Laboratories | $1,337.44 | 2019-2024 | Infinity |
| Dixi Medical USA Corp | $832.86 | 2022 | |
| Globus Medical, INC. | $818.27 | 2023 | Excelsius3d Imaging System |
| Medtronic, INC. | $606.91 | 2023-2025 | Percept PC Brainsense, Activa PC, Sensight |
| Neuropace, INC. | $252.56 | 2019-2022 | |
| Livanova USA, INC. | $154.77 | 2021-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Boston Scientific Corporation | $95.38 | 2023-2024 | Vercise |
| Baxter Healthcare | $78.95 | 2023-2024 | Floseal |
| Abbvie INC. | $65.15 | 2023 | Botox, Ubrelvy |
| Integra Lifesciences Corporation | $34.57 | 2024 | Codman Hakim, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Djo, LLC | $30.35 | 2025 | Cmf |
| Ucb, INC. | $24.07 | 2024 | Nayzilam |
| Smith+Nephew, INC. | $22.65 | 2025 | Pico 14 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $20.65 | 2023 | Nuplazid |
| Astrazeneca Pharmaceuticals LP | $20.19 | 2023 | Andexxa |
| Stryker Corporation | $16.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Romeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.